Oct 21, 2026, 2:59 PM
Descon Oxychem reports quarterly results for September 2026
Financial ResultDescon Oxychem’s board approved unaudited results for the quarter ended September 30, 2026, with no cash dividend, bonus shares, or rights shares. Consolidated sales, operating profit, net profit, and EPS increased year over year, while standalone operating profit and EPS were higher but profit before tax and net profit were nearly flat. The statements are in thousands of rupees.
Key Findings
- Consolidated quarterly net profit rose to Rs 159.306 million from Rs 135.696 million; EPS increased to Rs 0.91 from Rs 0.78.
- Consolidated sales increased to Rs 1,512.097 million from Rs 1,279.039 million, and operating profit rose to Rs 262.311 million from Rs 180.792 million.
- Standalone quarterly net profit was Rs 109.166 million versus Rs 108.517 million, while EPS remained Rs 0.62.
- The board recommended no cash dividend, bonus shares, or rights shares.
- Quarterly report to be transmitted separately through PUCARS.
Financial Performance
| Metric | PreviousThree-month period ended September 30, 2025 | CurrentThree-month period ended September 30, 2026 | Change |
|---|---|---|---|
| Consolidated sales | 1,279,039 | 1,512,097 | +18.2% |
| Consolidated gross profit | 301,951 | 394,430 | +30.6% |
| Consolidated operating profit | 180,792 | 262,311 | +45.1% |
| Consolidated net profit for the period | 135,696 | 159,306 | +17.4% |
| Consolidated earnings per share - basic and diluted | 0.78 | 0.91 | +16.7% |
| Consolidated finance cost | (4,024) | (23,119) | +474.5% |
| Consolidated bank balances | 393,708 | 491,826 | +24.9% |
| Standalone net profit for the period | 108,517 | 109,166 | +0.6% |
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.